Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 23 articles:
HTML format
Text format



Single Articles


    October 2017
  1. YANG X, Wang CC, Lee WYW, Trovik J, et al
    Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U.
    Cancer Lett. 2017 Oct 26. pii: S0304-3835(17)30665.
    PubMed     Text format     Abstract available


  2. WANG J, Man GCW, Chan TH, Kwong J, et al
    A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer.
    Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30623.
    PubMed     Text format     Abstract available


  3. PISTOLLATO F, Calderon Iglesias R, Ruiz R, Aparicio S, et al
    The use of natural compounds for the targeting and chemoprevention of ovarian cancer.
    Cancer Lett. 2017 Oct 7. pii: S0304-3835(17)30619.
    PubMed     Text format     Abstract available


  4. SHU T, Li Y, Wu X, Li B, et al
    Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment.
    Cancer Lett. 2017 Oct 6. pii: S0304-3835(17)30609.
    PubMed     Text format     Abstract available


    September 2017
  5. LOUGHRAN EA, Phan RC, Leonard AK, Tarwater L, et al
    Multiparity Activates Interferon Pathways in Peritoneal Adipose Tissue and Decreases Susceptibility to Ovarian Cancer Metastasis in a Murine Allograft Model.
    Cancer Lett. 2017 Sep 27. pii: S0304-3835(17)30581.
    PubMed     Text format     Abstract available


    July 2017
  6. SAKAI K, Ukita M, Schmidt J, Wu L, et al
    Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status.
    Cancer Lett. 2017 Jul 19. pii: S0304-3835(17)30439.
    PubMed     Text format     Abstract available


    May 2017
  7. SRIVASTAVA SK, Ahmad A, Zubair H, Miree O, et al
    MicroRNAs in gynecological cancers: Small molecules with big implications.
    Cancer Lett. 2017 May 24. pii: S0304-3835(17)30333.
    PubMed     Text format     Abstract available


  8. LAKSHMINARASIMHAN R, Andreu-Vieyra C, Lawrenson K, Duymich CE, et al
    Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
    Cancer Lett. 2017 May 5. pii: S0304-3835(17)30312.
    PubMed     Text format     Abstract available


    April 2017
  9. YANG C, Lim W, Bazer FW, Song G, et al
    Myricetin Suppresses Invasion and Promotes Cell Death in Human Placental Choriocarcinoma Cells through Induction of Oxidative Stress.
    Cancer Lett. 2017 Apr 17. pii: S0304-3835(17)30244.
    PubMed     Text format     Abstract available


  10. SOKOLENKO AP, Savonevich EL, Ivantsov AO, Raskin GA, et al
    Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.
    Cancer Lett. 2017 Apr 1. pii: S0304-3835(17)30218.
    PubMed     Text format     Abstract available


    February 2017
  11. HU Y, Li D, Wu A, Qiu X, et al
    TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.
    Cancer Lett. 2017 Feb 16. pii: S0304-3835(17)30109.
    PubMed     Text format     Abstract available


    January 2017
  12. DEAN M, Davis DA, Burdette JE
    Activin A Stimulates Migration of the Fallopian Tube Epithelium, an Origin of High-Grade Serous Ovarian Cancer, through Non-Canonical Signaling.
    Cancer Lett. 2017 Jan 20. pii: S0304-3835(17)30034.
    PubMed     Text format     Abstract available


    December 2016
  13. LUO T, Sun J, Zhu S, He J, et al
    Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30802.
    PubMed     Text format     Abstract available


  14. TODESCHINI P, Salviato E, Paracchini L, Ferracin M, et al
    Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: a validation across two independent cohorts.
    Cancer Lett. 2016 Dec 22. pii: S0304-3835(16)30780.
    PubMed     Text format     Abstract available


  15. AUER K, Bachmayr-Heyda A, Aust S, Grunt TW, et al
    Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer.
    Cancer Lett. 2016 Dec 7. pii: S0304-3835(16)30739.
    PubMed     Text format     Abstract available


    November 2016
  16. XIE G, Wang Z, Chen Y, Zhang S, et al
    Dual blocking of PI3K and mTOR signaling by NVP-BEZ235 inhibits proliferation in cervical carcinoma cells and enhances therapeutic response.
    Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30712.
    PubMed     Text format     Abstract available


  17. JEONG JY, Kang HY, Kim TH, Kim GI, et al
    MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
    Cancer Lett. 2016 Nov 22. pii: S0304-3835(16)30705.
    PubMed     Text format     Abstract available


    September 2016
  18. YOU J, Liu J, Bao Y, Wang L, et al
    SEI1 induces genomic instability by inhibiting DNA damage response in ovarian cancer.
    Cancer Lett. 2016 Sep 30. pii: S0304-3835(16)30574.
    PubMed     Text format     Abstract available


  19. LI Q, Zhang C, Chen R, Xiong H, et al
    Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Cancer Lett. 2016 Sep 28. pii: S0304-3835(16)30561.
    PubMed     Text format     Abstract available


    July 2016
  20. ZHANG L, Feng J, Kong S, Wu M, et al
    Nujiangexathone A, a novel compound from Garcinia nujiangensis, suppresses cervical cancer growth by targeting hnRNPK.
    Cancer Lett. 2016 Jul 14. pii: S0304-3835(16)30399.
    PubMed     Text format     Abstract available


    May 2016
  21. EVANS A, Jamieson SM, Liu DX, Wilson WR, et al
    Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model.
    Cancer Lett. 2016 May 27. pii: S0304-3835(16)30344.
    PubMed     Text format     Abstract available


  22. MIKAMI Y, Fukushima A, Komiyama Y, Iwase T, et al
    Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion.
    Cancer Lett. 2016 May 26. pii: S0304-3835(16)30341.
    PubMed     Text format     Abstract available


    April 2016
  23. LUO Z, Wang Q, Lau WB, Lau B, et al
    Tumor microenvironment: The culprit for ovarian cancer metastasis?
    Cancer Lett. 2016 Apr 27. pii: S0304-3835(16)30274.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: